# 4D Molecular Therapeutics, Inc.
> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
## Record
| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:61446dd8-308b-4fdb-9a36-eea449c21054 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 19 |
| Claims under review | 1 |
| Evidence records | 5 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-15T04:46:11.014891+00:00 |
| Last reviewed | 2026-10-15T04:46:11.014891+00:00 |
## Identity
- Legal name: 4D Molecular Therapeutics, Inc.
- Display name: 4D Molecular Therapeutics, Inc.
## Alpha Governance Record
| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-15T04:46:11.014891+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.831 |
| Directors | 9 |
| Committees | 1 |
| Governance events | 8 |
| Entity class | public_company |
## Section coverage
| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |
## Board
- Charles Theuer: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2015-01-01. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:6
- David Kirn, M.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2013-01-01. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:8
- Glenn Sblendorio: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-01-01. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:9
- Nancy Miller-Rich: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:11
- Shawn Cline Tomasello: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:12
- Susannah Gray: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:13
- David Kirn: Director, President and Chief Executive Officer. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: President and Chief Executive Officer (member). claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:7
- Jacob Chacko: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:10
- John F. Milligan: Director and Executive Chairman. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:5
## Committees
- President and Chief Executive Officer (executive). Chair: NOT_PUBLISHED. Members: David Kirn (member, unknown). committee_id=alpha:committee:4d-molecular-therapeutics-inc:president-and-chief-executive-officer
## Executive leadership
- David Kirn, M.D.: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:16
- Scott Bizily, J.D., Ph.D.: Chief Legal Officer and Corporate Secretary [GC]. Status: current. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:19
- Christopher Simms: Chief Commercial and Business Officer. Status: unknown. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:14
- David Kirn: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:15
- Kristian Humer: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:17
- Scott Bizily: Chief Legal Officer and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:18
## Governance events
- CEO_CHANGED: David Kirn, M.D. executive of 4D Molecular Therapeutics, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-15T04:46:11.014891+00:00. event_id=alpha:event:transition:hfqibt175j0an
- GC_CHANGED: Scott Bizily, J.D., Ph.D. executive of 4D Molecular Therapeutics, Inc., effective 2026-04-28. Effective: 2026-04-28. Detected: 2026-10-15T04:46:11.014891+00:00. event_id=alpha:event:transition:s1cxnb1e8fgo1
- DIRECTOR_APPOINTED: Glenn Sblendorio seat on 4D Molecular Therapeutics, Inc., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-15T04:46:11.014891+00:00. event_id=alpha:event:transition:op4xfm1apmuug
- DIRECTOR_APPOINTED: Nancy Miller-Rich seat on 4D Molecular Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-15T04:46:11.014891+00:00. event_id=alpha:event:transition:1tew30vvhfey3
- DIRECTOR_APPOINTED: Shawn Cline Tomasello seat on 4D Molecular Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-15T04:46:11.014891+00:00. event_id=alpha:event:transition:1aidwre1cdmros
- DIRECTOR_APPOINTED: Susannah Gray seat on 4D Molecular Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-15T04:46:11.014891+00:00. event_id=alpha:event:transition:1netptt141etep
- DIRECTOR_APPOINTED: Charles Theuer seat on 4D Molecular Therapeutics, Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-15T04:46:11.014891+00:00. event_id=alpha:event:transition:1c37mix15gqgvr
- DIRECTOR_APPOINTED: David Kirn, M.D. seat on 4D Molecular Therapeutics, Inc., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-15T04:46:11.014891+00:00. event_id=alpha:event:transition:fnatsr1815lzv
## Scoped resources
- `alpha://company/4d-molecular-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record
- `alpha://company/4d-molecular-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=identity
- `alpha://company/4d-molecular-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=corporate-structure
- `alpha://company/4d-molecular-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=board
- `alpha://company/4d-molecular-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=committees
- `alpha://company/4d-molecular-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=leadership
- `alpha://company/4d-molecular-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=ownership
- `alpha://company/4d-molecular-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=financials
- `alpha://company/4d-molecular-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=capital-structure
- `alpha://company/4d-molecular-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=compensation
- `alpha://company/4d-molecular-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=governance
- `alpha://company/4d-molecular-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=shareholder-governance
- `alpha://company/4d-molecular-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=audit
- `alpha://company/4d-molecular-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=legal
- `alpha://company/4d-molecular-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=risk
- `alpha://company/4d-molecular-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=cyber
- `alpha://company/4d-molecular-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=ai-governance
- `alpha://company/4d-molecular-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=agents
- `alpha://company/4d-molecular-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=ecosystem
- `alpha://company/4d-molecular-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=events
- `alpha://company/4d-molecular-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=relationships
- `alpha://company/4d-molecular-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=assessments
- `alpha://company/4d-molecular-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record§ion=evidence
## Role modules
- NOT_ASSERTED
## Attention
- NO_RECORDS_FOUND
## Committee data
- NO_RECORDS_FOUND
## Leadership
- John F. Milligan: Director and Executive Chairman. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6c21ef372431bf542d94718760db06ff345eb4b51cc166e17d5cd9db2663710.
- Charles Theuer: Director. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:6. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95e44af3aa0f2000d482bf79d42ab1f36f1ce83e68de4fd69428c585de6c6f0a.
- David Kirn: Director, President and Chief Executive Officer. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6c21ef372431bf542d94718760db06ff345eb4b51cc166e17d5cd9db2663710.
- David Kirn, M.D.: Director. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:8. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95e44af3aa0f2000d482bf79d42ab1f36f1ce83e68de4fd69428c585de6c6f0a.
- Glenn Sblendorio: Director. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:9. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95e44af3aa0f2000d482bf79d42ab1f36f1ce83e68de4fd69428c585de6c6f0a.
- Jacob Chacko: Director. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6c21ef372431bf542d94718760db06ff345eb4b51cc166e17d5cd9db2663710.
- Nancy Miller-Rich: Director. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:11. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95e44af3aa0f2000d482bf79d42ab1f36f1ce83e68de4fd69428c585de6c6f0a.
- Shawn Cline Tomasello: Director. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:12. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95e44af3aa0f2000d482bf79d42ab1f36f1ce83e68de4fd69428c585de6c6f0a.
- Susannah Gray: Director. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:13. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95e44af3aa0f2000d482bf79d42ab1f36f1ce83e68de4fd69428c585de6c6f0a.
- Christopher Simms: Chief Commercial and Business Officer. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6c21ef372431bf542d94718760db06ff345eb4b51cc166e17d5cd9db2663710.
- David Kirn: President and Chief Executive Officer. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6c21ef372431bf542d94718760db06ff345eb4b51cc166e17d5cd9db2663710.
- David Kirn, M.D.: President, Chief Executive Officer and Director. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:16. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ce30a281ead5bce2f489fc14c959316ac3d01718e2cd67c6bd59b77accad6371.
- Kristian Humer: Chief Financial Officer. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6c21ef372431bf542d94718760db06ff345eb4b51cc166e17d5cd9db2663710.
- Scott Bizily: Chief Legal Officer and Corporate Secretary. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d6c21ef372431bf542d94718760db06ff345eb4b51cc166e17d5cd9db2663710.
- Scott Bizily, J.D., Ph.D.: Chief Legal Officer and Corporate Secretary. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:leadership_role:19. Valid from: 2026-04-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cab7c27c3983e81d7121841a507d1fb330aed80845e1ac0f5f6a2ba647a1c34a.
## Roles
- PUBLISHED
## Governance
- NOT_ASSERTED
## Board committees
- PUBLISHED
## Financials
- NOT_ASSERTED
## Workforce
- NOT_ASSERTED
## Market and index context
- PUBLISHED
## Legal Name
- 4D Molecular Therapeutics, Inc.. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ec8896ef0fa3cb8ec4fa8eb8e3ae0199730bbddd9e856f3842d402756552ac84.
## Entity Status
- Public listing published. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ec8896ef0fa3cb8ec4fa8eb8e3ae0199730bbddd9e856f3842d402756552ac84.
## Published Fact
- US. Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ec8896ef0fa3cb8ec4fa8eb8e3ae0199730bbddd9e856f3842d402756552ac84.
## Security Listing
- FDMT (NASDAQ). Claim: alpha:claim:company:61446dd8-308b-4fdb-9a36-eea449c21054:security_listing:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ec8896ef0fa3cb8ec4fa8eb8e3ae0199730bbddd9e856f3842d402756552ac84.
## Coverage states
| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
## Public sources
- alpha:projection-evidence:ec8896ef0fa3cb8ec4fa8eb8e3ae0199730bbddd9e856f3842d402756552ac84: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc).
- alpha:projection-evidence:document:d6c21ef372431bf542d94718760db06ff345eb4b51cc166e17d5cd9db2663710: [SEC DEF 14A 0001140361-26-017427](https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm).
- alpha:projection-evidence:document:95e44af3aa0f2000d482bf79d42ab1f36f1ce83e68de4fd69428c585de6c6f0a: [DEF 14A ny20063669x1_def14a.htm](https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm).
- alpha:projection-evidence:document:ce30a281ead5bce2f489fc14c959316ac3d01718e2cd67c6bd59b77accad6371: [FDMT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm).
- alpha:projection-evidence:document:cab7c27c3983e81d7121841a507d1fb330aed80845e1ac0f5f6a2ba647a1c34a: [FDMT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm).
## Rights
| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
## Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
## Alternate representations
- [Canonical profile](https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/4d-molecular-therapeutics-inc` at https://mcp.alpha.ac/mcp
## Connected governance records
Structured intelligence is not currently available. Existing published profile evidence remains accessible.
## Critical-risk oversight
Snapshot as of 2026-10-15T21:12:59.81165+00:00; recorded 2026-10-15T21:12:59.81165+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.4D Molecular Therapeutics, Inc., for agents
The same record as the human view, as a structured object any agent can read and cite. Reading is open to every agent, model, and tool, with no key and no account. Signing and transparency logging are not yet published for this record.
- Alpha ID
- alpha:company:61446dd8-308b-4fdb-9a36-eea449c21054
- Version
- vpublic-1:ro-d751713988987e9331980363e24189ceRecorded Oct 15, 2026
- Content hash
- Not yet signed
- Signature
- Not yet signed
- Transparency log
- Not yet signed
- Freshness
- ObservedChecked Oct 15, 2026. Reviewed Oct 15, 2026
- Read access
- OpenNo key for public retrieval
- Processing basis
- Public recordDoctrine
Read
OpenOne canonical URL. The Accept header or a file suffix selects the format. Every format renders the same Claims and carries the same record version.
curl -H "Accept: application/json" https://registry.alpha.ac/companies/4d-molecular-therapeutics-incTrustCheck and Governance Receipts
Agent tierIllustrative. TrustChecks run in the private enterprise overlay. The example below is generated for this entity class and does not reference this record. Contract: TrustCheck and Governance Receipts v0.1.
Agents about to act ask a question, not for a document. A TrustCheck evaluates the AuthorityGrant objects behind a proposed action and returns allow, deny, require_approval, or insufficient_evidence. The source system acts, and a GovernanceReceipt records what the agent relied on.
- allow, deny
- The AuthorityGrant and policy decide. Reason codes name the rule.
- require_approval
- An entitled human records the decision. Customer policy sets the threshold, never an Eval.
- insufficient_evidence
- No authority is registered. Alpha never infers permission to act.
curl https://www.alpha.ac/v1/action-intents \
-H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" \
-d '{
"schema_version": "2026-08-29",
"environment": "test",
"actor": { "alpha_id": "alpha:account:self", "type": "alpha_account" },
"principal": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"organization": { "alpha_id": "alpha:company:example-issuer", "type": "organization" },
"proposed_action": { "type": "purchase_order.commit", "description": "Accept an order placed by an agent claiming company authority." },
"requested_authority": ["purchase_order.commit"]
}'
# then
curl https://www.alpha.ac/v1/trust-checks -H 'Content-Type: application/json' \
-b "$ALPHA_SESSION_COOKIE" -d '{ "action_intent_id": "<from the previous response>" }'{
"schema_version": "2026-08-29",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"decision": "insufficient_evidence",
"explanation": "No AuthorityGrant names this agent and organization.",
"reason_codes": [
"authority_grant_missing"
],
"evaluated_authority": {
"authority_grants": []
},
"policy_version": "trustcheck.registry-claim.test.v0.1",
"integrity_state": "recorded",
"limitations": [
"Illustrative example. No TrustCheck was run for this record."
]
}{
"schema_version": "2026-08-29",
"receipt_id": "alpha:receipt:illustrative-0001",
"environment": "test",
"actor": {
"alpha_id": "alpha:account:self",
"type": "alpha_account"
},
"agent": {
"provider": {
"alpha_id": "alpha:company:example-agent-provider",
"type": "provider"
},
"product": {
"alpha_id": "alpha:agent-product:example-procurement-agent",
"type": "agent_product"
},
"deployment": {
"alpha_id": "alpha:agent-deployment:example-deployment",
"type": "agent_deployment"
},
"use_case": {
"alpha_id": "alpha:agent-use-case:example-purchase-order",
"type": "agent_use_case"
},
"workflow": "Illustrative purchase order commitment"
},
"principal": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"sponsor": {
"alpha_id": "alpha:company:example-issuer",
"type": "organization"
},
"action_intent_id": "alpha:action-intent:illustrative-0001",
"trust_check_id": "alpha:trust-check:illustrative-0001",
"authority_grant_references": [],
"action_intent": {
"type": "purchase_order.commit"
},
"affected_alpha_ids": [
"alpha:company:example-issuer"
],
"trust_check_decision": "insufficient_evidence",
"policy_version": "trustcheck.registry-claim.test.v0.1",
"rule_references": [
{
"reason_code": "authority_grant_missing",
"rule_id": "trustcheck.authority_grant_missing",
"policy_ref": "trustcheck.registry-claim.test.v0.1",
"control_ref": null,
"grant_policy_references": []
}
],
"integrity": "Illustrative. Not issued, not signed."
}Connect
Open readEvery surface reads the same published record. No surface holds its own copy of the facts.
// claude_desktop_config.json, Cursor, or any MCP client
{
"mcpServers": {
"alpha": { "url": "https://mcp.alpha.ac/mcp" }
}
}
// This record as an MCP resource
alpha://companies/4d-molecular-therapeutics-incalpha://companies/4d-molecular-therapeutics-incThis record as an MCP resourcehttps://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc?format=recordThe same record over HTTP
Subscribe to changes
Agent tier, previewNo public subscription endpoint is published yet. Event delivery is part of Agent tier access, in preview. Access and availability.
CEO_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)GC_CHANGEDDerived governance event published on this record (alpha-governance-event-derivation-v2)DIRECTOR_APPOINTEDDerived governance event published on this record (alpha-governance-event-derivation-v2)
{
"specversion": "1.0",
"type": "ac.alpha.registry.CEO_CHANGED",
"source": "https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc",
"subject": "alpha:company:61446dd8-308b-4fdb-9a36-eea449c21054",
"data": {
"record_version": "public-1:ro-d751713988987e9331980363e24189ce",
"note": "Subscription delivery is Agent tier, preview. Not yet available publicly."
}
}Versions and changes
OpenRecords are versioned. Derived governance events on this record are listed below with the version that publishes them. Effective is the world time the derivation states; Recorded is when Alpha detected the event. Content hashes and log entries appear once records are signed.
| Version | Effective | Recorded | Content hash | Log entry | What changed |
|---|---|---|---|---|---|
| vpublic-1:ro-d751713988987e9331980363e24189ce | Apr 28, 2026 | Oct 15, 2026 | Not yet signed | Not yet signed | David Kirn, M.D. executive of 4D Molecular Therapeutics, Inc., effective 2026-04-28. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Apr 28, 2026 | Oct 15, 2026 | Not yet signed | Not yet signed | Scott Bizily, J.D., Ph.D. executive of 4D Molecular Therapeutics, Inc., effective 2026-04-28. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2026 | Oct 15, 2026 | Not yet signed | Not yet signed | Glenn Sblendorio seat on 4D Molecular Therapeutics, Inc., effective 2026-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 15, 2026 | Not yet signed | Not yet signed | Nancy Miller-Rich seat on 4D Molecular Therapeutics, Inc., effective 2020-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 15, 2026 | Not yet signed | Not yet signed | Shawn Cline Tomasello seat on 4D Molecular Therapeutics, Inc., effective 2020-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2020 | Oct 15, 2026 | Not yet signed | Not yet signed | Susannah Gray seat on 4D Molecular Therapeutics, Inc., effective 2020-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2015 | Oct 15, 2026 | Not yet signed | Not yet signed | Charles Theuer seat on 4D Molecular Therapeutics, Inc., effective 2015-01-01. |
| vpublic-1:ro-d751713988987e9331980363e24189ce | Jan 1, 2013 | Oct 15, 2026 | Not yet signed | Not yet signed | David Kirn, M.D. seat on 4D Molecular Therapeutics, Inc., effective 2013-01-01. |
Access, rights, and the public-role doctrine
Facts are open. Rights travel with every Claim and every Evidence record, so an agent sees the same terms whichever format it reads.
| Capability | Access | Agents |
|---|---|---|
| Alpha Disclosure sample | public | human process |
| Alpha public website | public | retrievable now |
| Alpha Standard, methodology, and research | public | retrievable now |
| Alpha Profiles (public executive and company records) | public | retrievable now |
| Public HTTP endpoints described by OpenAPI 3.1 | public | retrievable now |
| Alpha MCP public discovery and read-only capabilities | public | retrievable now |
| Alpha AI Readiness Eval | public | human process |
| Alpha Platform | approved access | requires approved access |
| Alpha API (authenticated operations) | approved access | requires approved access |
| Alpha MCP premium capabilities | approved access | requires approved access |
| Alpha Evals and verified assessments | custom | human process |
| Alpha Council membership | custom | human process |
| Alpha Institute education, workshops, and coaching | custom | human process |
| Governance diagnostics and institutional advisory | custom | human process |
Record limitations. Every representation states these in the same words; nothing is inferred as zero.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
}
"evidence_rights": {
"evidence_records": 5,
"redistribution_allowed": 0,
"restricted_or_unknown": 5,
"classified_unknown": 5
}"data_subject": {
"basis": "public_record",
"entity": "alpha:company:61446dd8-308b-4fdb-9a36-eea449c21054",
"identity_ownership": "unclaimed",
"rights": {
"public_retrieval": "allowed",
"agent_retrieval": "allowed",
"redistribution": "not_granted",
"model_training": "not_granted",
"commercial_use": "not_specified",
"relationship_pathfinding": "not_granted",
"direct_contact": "not_granted"
},
"requests": "https://www.alpha.ac/contact"
}How agents find this
OpenThe page head and every response carry rel="alternate" links and the Registry's Link header. The list below is generated from the same list the server emits.
/.well-known/ai-catalog.jsonAlpha Agentic Resource Discovery manifest/.well-known/api-catalogapi-catalog/.well-known/webmcp.jsonAlpha WebMCP tool discovery/openapi.jsonAlpha Governance Public Intelligence API (OpenAPI 3.1)/apiAlpha Intelligence API/developersAlpha Governance Developer Platform/docs/trustcheck-receipts-v01.mdTrustCheck and Governance Receipts v0.1 test preview/docs/apiAlpha service documentation/llms.txtAlpha service docs for AI agents/agents.mdAlpha agent instructions (when to use Alpha)/api-versioning.mdAlpha public API versioning and deprecation policy/.well-known/agent-skills/index.jsonAgent Skills Index/products/accessAlpha Access and Availability/api/public/product-accessAlpha Product Access and Availability JSON/api/public/auth-capabilitiesAlpha Authentication Capabilities JSON/peopleAlpha Executive Profiles/companiesAlpha Company Profiles/people/readinessAlpha Profile Coverage and Agent Readiness/api/public/profile-readinessAlpha Public Profile Readiness JSON/api/public/profiles/steven-wolfe-pereiraAlpha Public Profile JSON Example/.well-known/agent-card.jsonA2A Agent Card/.well-known/mcp/server-card.jsonMCP Server Card/.well-known/openid-configurationOpenID Configuration/.well-known/oauth-protected-resourceOAuth Protected Resource/.well-known/oauth-authorization-serverOAuth Authorization Server (agent_auth)/.well-known/agent-registrationAgent Registration/.well-known/http-message-signatures-directoryhttp-message-signatures-directory/.well-known/jwks-rotationJWKS Rotation Policy/auth.mdAgent Authentication/llms.txtSite overview for AI agents/sitemap.xmlsitemap/api/public/agent-readinessAgent Readiness Status/api/public/company-report/osw-market-dataOSW Market Data Verification
Record map and assertion states
| Section | Anchor | Resource | State | Claims |
|---|---|---|---|---|
| Identity | #c-subject | /identity | Published | 0 |
| Corporate structure | - | /corporate_structure | Not reviewed | - |
| Board | #c-board | /board | Published | 10 |
| Committees | #c-committees | /committees | Published | 0 |
| Leadership | #c-leadership | /leadership | Published | 5 |
| Ownership | #c-control | /ownership | Not reviewed | 0 |
| Financials | #c-financials | /financials | Not reviewed | 1 |
| Capital structure | - | /capital_structure | Published | - |
| Compensation | #c-comp | /compensation | Not reviewed | 0 |
| Governance | #c-governance | /governance | Not reviewed | 0 |
| Shareholder governance | - | /shareholder_governance | Not reviewed | - |
| Audit | - | /audit | Not reviewed | - |
| Legal | #c-legal | /legal | Not reviewed | 0 |
| Risk | #c-risk | /risk | Not reviewed | 0 |
| Cyber | - | /cyber | Not reviewed | - |
| AI governance | #c-ai | /ai_governance | Not reviewed | 0 |
| Agent governance | #c-authority | /agent_governance | Restricted | 0 |
| Markets external | - | /markets_external | Not reviewed | - |
| Events | #c-history | /events | Published | 8 |
| Relationships | #c-links | /relationships | Published | 15 |
| Assessments | #c-monitor | /assessments | Published | 0 |
| Evidence | #c-evidence | /evidence | Published | 5 |
- corroboratedTwo or more independent sources agree
- source_reportedOne cited source states it
- alpha_inferenceAlpha's conclusion, with reasoning
- not_disclosedSearched, nothing found. Never rendered as false
- not_reviewedNot yet searched
- not_registeredNo authority registered with Alpha



